Literature DB >> 26936260

The epidemiology of Takayasu arteritis: a hospital-based study from northwestern part of Turkey.

Fatih Saritas1,2, Salim Donmez3, Haner Direskeneli4, Omer Nuri Pamuk3.   

Abstract

Takayasu arteritis (TA) is a chronic, inflammatory large vessel vasculitis that affects aorta and its main branches. We aimed to evaluate the incidence and prevalence of TA in the northwestern part of Turkey. We retrospectively evaluated 23 TA patients followed by our clinic. Clinical features, treatments and responses were recorded. Our hospital is the single tertiary referral center for rheumatic diseases for a mixed rural and urban population of 620,447 people for >16 years (306,036 males, 314,411 females). Nineteen of the 23 patients were females (82.6 %) and four were males (17.4 %). The annual incidence rate for TA was 0.34/100,000. The overall prevalence of TA in our region was 3.3/100,000 (95 % CI 1.9-4.8) in individuals >16 years. The most common findings at the time of presentation were blood pressure difference (73 %) and headache (60.4 %). The most common angiographic type was type 1 (12 patients, 52.2 %). Median follow-up period was 48 months (range 10-132). Three (13 %) of the patients had stent replacements to different vascular sites. One patient had an operation for aortic aneurysm, and aortic valve replacement surgery has been made. One patient had renal artery bypass operation. Eleven patients (47.8 %) had recurrency at follow-up period and two patients (8.7 %) died. In northwestern part of Turkey, the annual incidence and prevalence of TA were higher than western population, but similar to East Asian data.

Entities:  

Keywords:  Epidemiology; Large vessel vasculitis; Pulseless disease; Takayasu arteritis

Mesh:

Year:  2016        PMID: 26936260     DOI: 10.1007/s00296-016-3445-z

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  31 in total

Review 1.  Takayasu arteritis in Israel.

Authors:  T Rosenthal; B Morag; Y Itzchak
Journal:  Heart Vessels Suppl       Date:  1992

Review 2.  Retrospective evaluation of 22 patients with Takayasu's arteritis.

Authors:  Nazife Sule Yasar Bilge; Timuçin Kaşifoğlu; Döndü U Cansu; Cengiz Korkmaz
Journal:  Rheumatol Int       Date:  2011-01-20       Impact factor: 2.631

3.  Angiographic findings of Takayasu arteritis: new classification.

Authors:  A Hata; M Noda; R Moriwaki; F Numano
Journal:  Int J Cardiol       Date:  1996-08       Impact factor: 4.164

4.  Takayasu's arteritis: a hospital-region based study on occurrence, treatment and prognosis.

Authors:  A U Waern; P Andersson; A Hemmingsson
Journal:  Angiology       Date:  1983-05       Impact factor: 3.619

5.  Takayasu arteritis in Thailand: clinical and imaging features.

Authors:  N Suwanwela; C Piyachon
Journal:  Int J Cardiol       Date:  1996-08       Impact factor: 4.164

6.  Stable incidence of primary systemic vasculitides over five years: results from the German vasculitis register.

Authors:  Eva Reinhold-Keller; Karen Herlyn; Rosemarie Wagner-Bastmeyer; Wolfgang L Gross
Journal:  Arthritis Rheum       Date:  2005-02-15

7.  Early and long-term results of subclavian angioplasty in aortoarteritis (Takayasu disease): comparison with atherosclerosis.

Authors:  S Tyagi; P K Verma; D S Gambhir; U A Kaul; R Saha; R Arora
Journal:  Cardiovasc Intervent Radiol       Date:  1998 May-Jun       Impact factor: 2.740

8.  Anti-tumor necrosis factor therapy in patients with difficult to treat Takayasu arteritis.

Authors:  Gary S Hoffman; Peter A Merkel; Richard D Brasington; Deborah J Lenschow; Patrick Liang
Journal:  Arthritis Rheum       Date:  2004-07

9.  Development and initial validation of the Indian Takayasu Clinical Activity Score (ITAS2010).

Authors:  Ramnath Misra; Debashish Danda; Sivakumar M Rajappa; Alakendu Ghosh; Rajiva Gupta; Kurugodu M Mahendranath; Lakshmanan Jeyaseelan; Able Lawrence; Paul A Bacon
Journal:  Rheumatology (Oxford)       Date:  2013-04-16       Impact factor: 7.580

10.  Takayasu arteritis.

Authors:  G S Kerr; C W Hallahan; J Giordano; R Y Leavitt; A S Fauci; M Rottem; G S Hoffman
Journal:  Ann Intern Med       Date:  1994-06-01       Impact factor: 25.391

View more
  7 in total

1.  Cyclophosphamide could be a better choice than methotrexate as induction treatment for patients with more severe Takayasu's arteritis.

Authors:  Ying Sun; Lili Ma; Lingying Ma; Xiufang Kong; Huiyong Chen; Peng Lv; Jiang Lin; Hao Liu; Yan Yan; Zongfei Ji; Chengde Yang; Shengming Dai; Weiguo Wan; Yaohong Zou; Xuejuan Jin; Lindi Jiang
Journal:  Rheumatol Int       Date:  2017-10-13       Impact factor: 2.631

Review 2.  Takayasu Arteritis: Recent Developments.

Authors:  Maria L F Zaldivar Villon; Jose A Leon de la Rocha; Luis R Espinoza
Journal:  Curr Rheumatol Rep       Date:  2019-07-18       Impact factor: 4.592

Review 3.  Large-vessel vasculitis.

Authors:  Dan Pugh; Maira Karabayas; Neil Basu; Maria C Cid; Ruchika Goel; Carl S Goodyear; Peter C Grayson; Stephen P McAdoo; Justin C Mason; Catherine Owen; Cornelia M Weyand; Taryn Youngstein; Neeraj Dhaun
Journal:  Nat Rev Dis Primers       Date:  2022-01-06       Impact factor: 65.038

4.  The clinical characteristics of Chinese Takayasu's arteritis patients: a retrospective study of 411 patients over 24 years.

Authors:  Jing Li; Fei Sun; Zhe Chen; Yunjiao Yang; Jiuliang Zhao; Mengtao Li; Xinping Tian; Xiaofeng Zeng
Journal:  Arthritis Res Ther       Date:  2017-05-25       Impact factor: 5.156

5.  Tuberculosis in Takayasu arteritis: a retrospective study in 1105 Chinese patients.

Authors:  Ying Zhang; Peng Fan; Fang Luo; Hui-Min Zhang; Lei Song; Wen-Jun Ma; Hai-Ying Wu; Jun Cai; Lin-Ping Wang; Xian-Liang Zhou
Journal:  J Geriatr Cardiol       Date:  2019-08       Impact factor: 3.327

Review 6.  Global epidemiology of vasculitis.

Authors:  Richard A Watts; Gulen Hatemi; Jane C Burns; Aladdin J Mohammad
Journal:  Nat Rev Rheumatol       Date:  2021-12-01       Impact factor: 20.543

7.  A systematic review and meta-analysis of the incidence rate of Takayasu arteritis.

Authors:  Megan Rutter; Jonathan Bowley; Peter C Lanyon; Matthew J Grainge; Fiona A Pearce
Journal:  Rheumatology (Oxford)       Date:  2021-11-03       Impact factor: 7.580

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.